Comparison between Plethico Pharmaceuticals IPO and Reliance Petroleum IPO.
Plethico Pharmaceuticals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Reliance Petroleum IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Plethico Pharmaceuticals IPO | Reliance Petroleum IPO | |
|---|---|---|
| Logo | ||
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | ||
| Registrar | ||
| Market Maker | ||
| DRHP | ||
| RHP | ||
| Final Prospectus | Final Prospectus  | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Plethico Pharmaceuticals IPO is up to ₹110.00 Cr whereas the issue size of the Reliance Petroleum IPO is up to ₹2,700.00 Cr. The final issue price of Plethico Pharmaceuticals IPO is ₹300.00 per share and of Reliance Petroleum IPO is ₹60.00 per share.
| Plethico Pharmaceuticals IPO | Reliance Petroleum IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹280.00 per share | ₹57.00 per share |
| Issue Price (Upper) | ₹300.00 per share | ₹62.00 per share |
| Issue Price (Final) | ₹300.00 per share | ₹60.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 36,66,667 shares | 45,00,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹110.00 Cr | up to ₹2,700.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 36,66,667 shares | 45,00,00,000 shares |
| Issue Size Total (Amount) | up to ₹110.00 Cr | up to ₹2,700.00 Cr |
Plethico Pharmaceuticals IPO opens on Apr 10, 2006, while Reliance Petroleum IPO opens on Apr 13, 2006. The closing date of Plethico Pharmaceuticals IPO and Reliance Petroleum IPO is Apr 17, 2006, and Apr 20, 2006, respectively.
Plethico Pharmaceuticals IPO P/E ratio is , as compared to Reliance Petroleum IPO P/E ratio of .
| Plethico Pharmaceuticals IPO | Reliance Petroleum IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | 97.5 | 85.71 |
| Promoter Shareholding (Post-Issue) | 87.01 | 75 |
| P/E Ratio | ||
| Market Cap | ₹1022.00 Cr. | ₹27000.00 Cr. |
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Plethico Pharmaceuticals IPO Retail Individual Investors (RII) are offered 11,00,000 shares while in Reliance Petroleum IPO retail investors are offered 11,00,000 shares. Qualified Institutional Buyers (QIB) are offered 22,00,000 shares in Plethico Pharmaceuticals IPO and 27,00,00,000 shares in Reliance Petroleum IPO.
| Plethico Pharmaceuticals IPO | Reliance Petroleum IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 22,00,000 shares | 27,00,00,000 shares |
| NII | 3,66,667 shares | 4,50,00,000 shares |
| RII | 11,00,000 shares | 13,50,00,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 36,66,667 shares | 45,00,00,000 shares |
Plethico Pharmaceuticals IPO subscribed in total, whereas Reliance Petroleum IPO subscribed .
